/saigenci/ en /saigenci/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost Researchers from the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI), based at the ÐÓ°ÉÖ±²¥ of Adelaide, have been awarded funding to further their work in prostate and pancreatic cancers. December 18 2024 Debbie Wellington /saigenci/news/list/2024/12/18/saigenci-researchers-given-a-funding-boost /saigenci/news/list/2024/06/17/movember-and-saigenci-partner-on-landmark-database-to-drive-improvements-in Movember, the leading global men’s health charity, has partnered with the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI) at the ÐÓ°ÉÖ±²¥ of Adelaide, to create a transformative database that will help researchers develop strategies for clinicians to personalise decisions about prostate cancer care. October 18 2024 Debbie Wellington /saigenci/news/list/2024/06/17/movember-and-saigenci-partner-on-landmark-database-to-drive-improvements-in /saigenci/news/list/2023/05/18/an-dieu-trang-nguyen-awarded-inaugural-david-beale-scholarship-in-prostate May 19 2023 Debbie Wellington /saigenci/news/list/2023/05/18/an-dieu-trang-nguyen-awarded-inaugural-david-beale-scholarship-in-prostate /saigenci/news/list/2023/05/12/unlocking-the-mysteries-of-prostate-cancer The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention. May 12 2023 Sarah Cervone /saigenci/news/list/2023/05/12/unlocking-the-mysteries-of-prostate-cancer /saigenci/news/list/2023/03/28/enzamet-shows-promise-as-prostate-cancer-treatment The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI) that operates within the ÐÓ°ÉÖ±²¥ of Adelaide, have been published today in The Lancet Oncology . March 28 2023 Debbie Wellington /saigenci/news/list/2023/03/28/enzamet-shows-promise-as-prostate-cancer-treatment